Lithium Street, page-29

First 29 Last

Share
Profile

Follow
Crusaders95

992 Posts.

262

27/09/23

17:06

Post #: 70057774
Share

Originally posted by VascoBlack: ↑

Maybe just boredom, waiting for permission to drill against a backdrop of poor markets.......

Being a bit of a stock watcher my 2 cents worth, if you want to play this Creasy/AZS nearology game, are:

1) Take a shot gun approach and a pozzie in all players, Raiders of the Lost Stock, Artur's anus (once used by dave full o gas) , Error wozzer here, NoGo on the sauces and Been Greek Dining. Rational can't get too smart regarding trends and distance from fertile granite margins, outcrop on surface etc........too many variables.

BUT

2) Buy after the bun rush.......the bored players sell out as the interminable wait for the permission to drill and contractor mobilisation becomes interminable and all those other stocks can't be chased because money is stuck in this suckky Li stock without even a drill hole, My guess is buy sometime in the next 2-3 weeks.
3) Wait patiently it now won't be interminable
4) Sell 50-70% on announcement of commencement of drilling, ( keep a toe in the water, but ditch >50%)
5) A bit after announcement of first drill results ( unless one of these nearology boys hits big straight out of the gate which is a buy with both hands scenario) buy back in. Rationale - most likely first results will either be duds or skinny hits. Second or third round results will zero onto the goods.

IMO
Buy Levels GRE ~ 0.32 Sell 0.55 on announcement to drill.

Sentiment (category not available): Watchin

Expand

Buy .32?

I've got this stock in a bullish penant pattern.

Today tested the lower boundary - Also to note --- there are 250 assay samples still pending (as the next bump we need).

GRE Price at posting: 40.0¢ Sentiment: Buy Disclosure: Not Held
4 Upvote

0 Great analysis

Reply

Top Stories

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

First 29 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 4.3¢		Change 0.000(0.00%)		Mkt cap ! $4.875M

Open	High	Low	Value	Volume
4.2¢	4.3¢	4.2¢	$5.623K	131.9K

Buyers (Bids)

No.	Vol.	Price($)
1	21612	4.2¢

Sellers (Offers)

Price($)	Vol.	No.
4.3¢	100000	1

View Market Depth

No.	Vol.	Price($)
1	21612	0.042
2	97021	0.041
8	297500	0.040
2	536451	0.039
1	100000	0.038

Price($)	Vol.	No.
0.043	100000	1
0.044	104466	2
0.047	68204	2
0.050	121055	2
0.054	137166	2

Last trade - 12.25pm 27/06/2025 (20 minute delay)

GRE (ASX) Chart

Lithium Street, page-29

Australia’s gas crisis is here – and dying coal plants aren’t helping

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Lithium Street, page-29

Top Stories

Australia’s gas crisis is here – and dying coal plants aren’t helping

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News